Surgeons Make the Call on Gene Tests for Breast Cancer Patients
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 3, 2018 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Research, News, Source Type: news

Surgeons Make the Call on Gene Tests for Breast Cancer Patients
TUESDAY, July 3, 2018 -- When it comes to genetic testing for breast cancer patients, their surgeons wield great influence on that decision, new research shows. Genetic testing can provide important information that might affect treatment choices... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2018 Category: General Medicine Source Type: news

Medical News Today: Targeting the enzyme with a dual role in breast and brain health
One enzyme plays key roles in both breast cancer and intellectual disability. Knowing more about its molecular structure could help to design better drugs. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2018 Category: Consumer Health News Tags: Biology / Biochemistry Source Type: news

Surgeons have substantial impact on genetic testing in breast cancer patients who need it
(Michigan Medicine - University of Michigan) A new study finds surgeon attitudes about genetic testing have a big impact on whether women receive testing after a breast cancer diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

Surgeons Make the Call on Gene Tests for Breast Cancer Patients
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

Roche reports good news in breast cancer combo trial
Roche announced that a Phase III trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 2, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer
First Phase III immunotherapy study to demonstrate a statistically significant progression-free survival (PFS) improvement in intention-to-treat (ITT) and PD-L1 positive first-line metastatic triple negative breast cancer (TNBC) populations Encouraging ... Biopharmaceuticals, Oncology Genentech, Roche Group, TECENTRIQ, atezolizumab, triple negative, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 2, 2018 Category: Pharmaceuticals Source Type: news

Roche 'highly encouraged' by Tecentriq results in breast cancer
ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer. (Source: Reuters: Health)
Source: Reuters: Health - July 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Phase III IMpassion130 study showed Roche ’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer
Roche today announced that the Phase III IMpassion130 study met its co-primary endpoint of progression-free survival (PFS). (Source: Roche Investor Update)
Source: Roche Investor Update - July 2, 2018 Category: Pharmaceuticals Source Type: news

Phase III IMpassion130 study showed Roche ’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer
Roche today announced that the Phase III IMpassion130 study met its co-primary endpoint of progression-free survival (PFS). (Source: Roche Media News)
Source: Roche Media News - July 2, 2018 Category: Pharmaceuticals Source Type: news

What the satellites in your body do
(Salk Institute) Salk scientists studying satellite RNAs discovered that a specific type called hSATa induces breast cancer by directly interfering with DNA copying and damage repair. The research, which appeared in the journal Molecular Cell on June 7, 2018, suggests that targeting satellite RNAs could provide another approach for treating multiple types of cancer, including breast, ovarian, prostate and pancreatic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 2, 2018 Category: Cancer & Oncology Source Type: news

Is risk-stratified breast cancer screening a better option?
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - July 1, 2018 Category: Drugs & Pharmacology Source Type: news

Sharing Mayo Clinic: 2 Teams, 1 Mission: Defeat Breast Cancer
Diagnosed with an aggressive form of breast cancer, Elena Blevins worked with providers at Phoenix Indian Medical Center and Mayo Clinic through a collaboration that provides patients with comprehensive cancer care. Elena Blevins spends much of her time caring for others. Her career as an aide takes her into the homes of elderly individuals, where [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 1, 2018 Category: Databases & Libraries Source Type: news

Puma Biotech gets EU panel nod for breast cancer drug
(Reuters) - Puma Biotechnology Inc   on Friday won a key recommendation from a European Medicines Agency panel on its lead breast cancer drug, five months after the regulator recommended against approving it. (Source: Reuters: Health)
Source: Reuters: Health - June 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Enzyme may get key role in drug design for breast cancer and brain condition
(University of Copenhagen The Faculty of Health and Medical Sciences) In recent years, researchers have focused on the enzyme TLK2 suspecting it of playing a main role in several diseases. A new study conducted at the University of Copenhagen now reveals that the enzyme displays lower levels of activity in intellectual disability and that it is possible to inhibit it in breast cancer, where it is overactive. The study thus suggests that the enzyme may be a target for potential therapies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - June 29, 2018 Category: Biology Source Type: news

Breast cancer studies overlook socioeconomic factors
Social factors such as race and economic position influence women's vulnerability...Read more on AuntMinnie.comRelated Reading: ACR, SBI: Some black women need earlier breast screening Race matters for breast cancer screening protocols Gap narrows in black, white breast cancer death rates USPSTF: Why do more black women die from breast cancer? CDC: Breast cancer death rate declines, but not equally (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 28, 2018 Category: Radiology Source Type: news

Male Breast Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 28, 2018 Category: General Medicine Source Type: news

Could More Vitamin D Help Prevent Breast Cancer?
Title: Could More Vitamin D Help Prevent Breast Cancer?Category: Health NewsCreated: 6/27/2018 12:00:00 AMLast Editorial Review: 6/28/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 28, 2018 Category: Cancer & Oncology Source Type: news

USPSTF reaffirms osteoporosis screening
Women 65 years and older should be screened regularly for osteoporosis, according...Read more on AuntMinnie.comRelated Reading: USPSTF opens review of CT lung screening guidance USPSTF again nixes screening for ovarian cancer USPSTF rejects adding new risk factors for heart disease USPSTF's breast cancer screening recs dampen compliance USPSTF to review osteoporosis screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 28, 2018 Category: Radiology Source Type: news

Could More Vitamin D Help Prevent Breast Cancer?
The U.S. National Cancer Institute estimates there will be more than 266,000 new breast cancer cases among U.S. women this year and 40,900 breast cancer deaths. (Source: WebMD Health)
Source: WebMD Health - June 28, 2018 Category: Consumer Health News Source Type: news

Could More Vitamin D Help Prevent Breast Cancer?
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 28, 2018 Category: Cancer & Oncology Source Type: news

Could More Vitamin D Help Prevent Breast Cancer?
WEDNESDAY, June 27, 2018 -- High levels of vitamin D may reduce a woman's risk of breast cancer, a new study suggests. Researchers looked at more than 5,000 women, 55 and older, and found that those with vitamin D blood levels of 60 nanograms per... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 27, 2018 Category: General Medicine Source Type: news

Higher Rates of Cancers Observed Among Flight Attendants
Especially breast cancer, melanoma, and non - melanoma skin cancer among female flight attendants (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 27, 2018 Category: Cancer & Oncology Tags: Dermatology, Gynecology, Internal Medicine, Oncology, Journal, Source Type: news

NIH study associates obesity with lower breast cancer risk in young women
The development of breast cancer is relatively rare before menopause. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 27, 2018 Category: American Health Source Type: news

NIH Opening First Mesothelioma Clinical Trial for Lynparza
The National Institutes of Health (NIH) in Bethesda, Maryland, is opening the first mesothelioma clinical trial involving the immunotherapy drug Lynparza (olaparib), a protein inhibitor and targeted therapy already used effectively with breast and ovarian cancers. The phase II clinical trial, for patients previously treated with standard chemotherapy, is designed to gauge the response rate in pleural and peritoneal mesothelioma. Mesothelioma specialist Dr. Raffit Hassan of the National Cancer Institute (NCI) is the senior investigator for the single-center trial, which hopes to enroll at least 40 patients. Earlier research...
Source: Asbestos and Mesothelioma News - June 27, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Breast cancer studies ignore race, socioeconomic factors
(Johns Hopkins University Bloomberg School of Public Health) Studies of breast cancer risk and treatment outcomes are not taking sufficient account of race/ethnicity, economic status, education level, health insurance status and other social factors, according to scientists at Johns Hopkins Bloomberg School of Public Health. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 27, 2018 Category: International Medicine & Public Health Source Type: news

NIH study associates obesity with lower breast cancer risk in young women
(NIH/National Institute of Environmental Health Sciences) Young women with high body fat have a decreased chance of developing breast cancer before menopause, according to scientists at the National Institutes of Health and their collaborators. The finding, published online in the journal JAMA Oncology, may help researchers better understand the role obesity plays in breast cancer risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 27, 2018 Category: Cancer & Oncology Source Type: news

Could More Vitamin D Help Prevent Breast Cancer?
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 27, 2018 Category: Cancer & Oncology Source Type: news

Puma Biotech breast cancer drug likely approved in Europe after reexamination
A committee of the European Medicines Agency is likely to approve the drug, five months after regulators recommended against approval (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - June 26, 2018 Category: Pharmaceuticals Source Type: news

Zoledronic Acid Prevents Bone Loss in Premenopausal Breast-Cancer Patients Zoledronic Acid Prevents Bone Loss in Premenopausal Breast-Cancer Patients
Zoledronic acid can prevent treatment-related bone loss in premenopausal breast-cancer patients, and the benefit persists for up to three years after treatment, according to new findings.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

TRBV Gene Use Could Act as Biomarker in HER2+ Breast Cancer
Direct measurements of TRBV genes could provide a biomarker to predict response to dual HER2 blockade in women with HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - June 26, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Pfizer's Breast Cancer Drug Combo Falls Short of Survival Goal Pfizer's Breast Cancer Drug Combo Falls Short of Survival Goal
Pfizer Inc said on Monday a combination of its breast cancer drug, Ibrance (palbociclib), and fulvestrant was not statistically significant in extending overall survival in women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer whose disease has progressed after prior endocrine therapy.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Study Confirms Dense Breasts Are Prone to Cancer
A large new study out of Norway confirms that women with dense breasts are more likely to be diagnosed with cancer. About half of American women who are screened for breast cancer have dense breast tissue. "Dense breasts are not something that a patient feels. You can only tell if someone has dense breast tissue on a mammogram," an expert says. (Source: WebMD Health)
Source: WebMD Health - June 26, 2018 Category: Consumer Health News Source Type: news

Oklahoma mother believes CBD oil cured her stage four breast cancer
Rhonda Gossett, a mother-of-one from Edmond, Oklahoma, said she believes that CBD oil cured her stage four breast cancer, although doctors say they are not as sure. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Images show which breasts are most likely to become cancerous
Researchers, from the Cancer Registry of Norway, Oslo, found that of women with dense tissue, 6.7 per 100,000 develop breast cancer compared to 5.5 per 100,000 without. (Source: the Mail online | Health)
Source: the Mail online | Health - June 26, 2018 Category: Consumer Health News Source Type: news

Puma Biotech says Europe likely to approve breast cancer drug
(Reuters) - Puma Biotechnology Inc said on Tuesday a committee of the European Medicines Agency was likely to give positive opinion on its breast cancer drug, five months after the regulator recommended against approving it. (Source: Reuters: Health)
Source: Reuters: Health - June 26, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Study Confirms Denser Breasts Are More Prone to Cancer
TUESDAY, June 26, 2018 -- Using automated breast density measurements, Norwegian researchers were able to more precisely confirm that women with dense breasts have a higher risk of breast cancer. The study included more than 100,000 women and more... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 26, 2018 Category: General Medicine Source Type: news

Polio Virus Could Help Treat Brain Cancer. Here ’s How
The idea that viruses may be co-opted to do good rather than harm isn’t entirely new; researchers have been attempting to harness the power of viruses and bacteria for more than a century. Vaccines are the shining example of using bad bugs to do good in priming the immune system to fight disease. But disease-causing viruses aren’t always easy to corral, and attempts to use them to activate the immune system against things other than fellow bacteria and viruses — including cancer, for example — have not been so successful. There is only one approved virus-based treatment for cancer, which uses herpes...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Dense breast tissue translates into higher cancer odds
A large study out of Norway found that women with dense breast tissue do have...Read more on AuntMinnie.comRelated Reading: Synthesized 2D mammo works well for density assessment Age, not density, predicts interval breast cancer result Automated breast density assessment informs cancer risk Deep-learning algorithm can assess breast density Breast density laws mystify primary care providers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 26, 2018 Category: Radiology Source Type: news

New study confirms higher cancer rate in women with dense breast tissue
(Radiological Society of North America) Researchers using automated breast density measurements have found that women with mammographically dense breast tissue have higher recall and biopsy rates and increased odds of screen-detected and interval breast cancer, according to a large new study. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

New regulatory axis revealed for the cancer relevant matrix metalloprotease MMP14
(University of Helsinki) Membrane-associated metalloprotease, MMP14, plays a significant role in different cancer tissues -- for instance in breast cancer and melanoma patients high MMP14 levels increase the risk to develop metastasis. The study, conducted at the University of Helsinki, revealed that Prox1 negatively regulates MMP14 protein levels by suppressing transcription of the MMP14 gene. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 26, 2018 Category: International Medicine & Public Health Source Type: news

BMI Inversely Associated With Risk of Premenopausal Breast Cancer
The inverse association with premenopausal breast cancer was seen across the entire distribution of BMI, and at a higher magnitude than previously reported. (Source: CancerNetwork)
Source: CancerNetwork - June 26, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Flight Attendants Have Higher Rates of Many Cancers, Study Says
Flight attendants are exposed to a number of known cancer-causing risks, but few studies have rigorously quantified that risk, and researchers say they are an understudied occupational group. The Harvard Flight Attendant Health Study (FAHS), begun in 2007, addresses some of the gaps in understanding health risks among flight attendants. In the latest report, published in the journal Environmental Health, researchers found that flight attendants had higher rates of many cancers, including breast cancer and melanoma, compared to the general population. The FAHS included more than 5,300 flight attendants who were recruited th...
Source: TIME: Health - June 26, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer healthytime Source Type: news

Study Confirms Denser Breasts Are More Prone to Cancer
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Flight Attendants Show Higher Cancer Risks
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Study Confirms Denser Breasts Are More Prone to Cancer
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Flight Attendants Show Higher Cancer Risks
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - June 26, 2018 Category: Cancer & Oncology Source Type: news

Annals: Overdiagnosis must be better defined
The problem of overdiagnosis in cancer screening has been hotly debated for...Read more on AuntMinnie.comRelated Reading: People want cancer screening, despite pitfalls How serious is the risk of breast cancer overdiagnosis? Is the mammography debate an example of 'fake science'? Women still value mammography's benefits over 'harms' Why is thyroid cancer being overdiagnosed in Canada? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 25, 2018 Category: Radiology Source Type: news

Metastatic Breast Cancer Center of Excellence | Medscape Metastatic Breast Cancer Center of Excellence | Medscape
In-depth clinical information, medical news, guidelines on metastatic breast cancer. Includes the latest research, journal articles, Medscape TV, cases, quizzes, and peer-to-peer discussion of the challenges of treating metastatic breast cancer. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 25, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news